Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Sci Rep ; 9(1): 420, 2019 01 23.
Article in English | MEDLINE | ID: mdl-30674978

ABSTRACT

Obesity increases the risk for cardiometabolic diseases. N-acyl phosphatidylethanolamines (NAPEs) are precursors of N-acylethanolamides, which are endogenous lipid satiety factors. Incorporating engineered bacteria expressing NAPEs into the gut microbiota retards development of diet induced obesity in wild-type mice. Because NAPEs can also exert anti-inflammatory effects, we hypothesized that administering NAPE-expressing bacteria to low-density lipoprotein receptor (Ldlr)-/- mice fed a Western diet would improve various indices of cardiometabolic disease manifested by these mice. NAPE-expressing E. coli Nissle 1917 (pNAPE-EcN), control Nissle 1917 (pEcN), or vehicle (veh) were given via drinking water to Ldlr-/- mice for 12 weeks. Compared to pEcN or veh treatment, pNAPE-EcN significantly reduced body weight and adiposity, hepatic triglycerides, fatty acid synthesis genes, and increased expression of fatty acid oxidation genes. pNAPE-EcN also significantly reduced markers for hepatic inflammation and early signs of fibrotic development. Serum cholesterol was reduced with pNAPE-EcN, but atherosclerotic lesion size showed only a non-significant trend for reduction. However, pNAPE-EcN treatment reduced lesion necrosis by 69% indicating an effect on preventing macrophage inflammatory death. Our results suggest that incorporation of NAPE expressing bacteria into the gut microbiota can potentially serve as an adjuvant therapy to retard development of cardiometabolic disease.


Subject(s)
Cardiovascular Diseases , Escherichia coli/growth & development , Gastrointestinal Microbiome , Liver Cirrhosis , Liver/metabolism , Phosphatidylethanolamines/biosynthesis , Receptors, LDL/deficiency , Animals , Cardiovascular Diseases/genetics , Cardiovascular Diseases/metabolism , Cardiovascular Diseases/microbiology , Cardiovascular Diseases/prevention & control , Fatty Acids/genetics , Fatty Acids/metabolism , Liver/pathology , Liver Cirrhosis/genetics , Liver Cirrhosis/metabolism , Liver Cirrhosis/microbiology , Liver Cirrhosis/prevention & control , Mice , Triglycerides/genetics , Triglycerides/metabolism
2.
mBio ; 7(1): e01725-15, 2016 Jan 05.
Article in English | MEDLINE | ID: mdl-26733066

ABSTRACT

UNLABELLED: Bacterial interspecies interactions play clinically important roles in shaping microbial community composition. We observed that Corynebacterium spp. are overrepresented in children free of Streptococcus pneumoniae (pneumococcus), a common pediatric nasal colonizer and an important infectious agent. Corynebacterium accolens, a benign lipid-requiring species, inhibits pneumococcal growth during in vitro cocultivation on medium supplemented with human skin surface triacylglycerols (TAGs) that are likely present in the nostrils. This inhibition depends on LipS1, a TAG lipase necessary for C. accolens growth on TAGs such as triolein. We determined that C. accolens hydrolysis of triolein releases oleic acid, which inhibits pneumococcus, as do other free fatty acids (FFAs) that might be released by LipS1 from human skin surface TAGs. Our results support a model in which C. accolens hydrolyzes skin surface TAGS in vivo releasing antipneumococcal FFAs. These data indicate that C. accolens may play a beneficial role in sculpting the human microbiome. IMPORTANCE: Little is known about how harmless Corynebacterium species that colonize the human nose and skin might impact pathogen colonization and proliferation at these sites. We show that Corynebacterium accolens, a common benign nasal bacterium, modifies its local habitat in vitro as it inhibits growth of Streptococcus pneumoniae by releasing antibacterial free fatty acids from host skin surface triacylglycerols. We further identify the primary C. accolens lipase required for this activity. We postulate a model in which higher numbers of C. accolens cells deter/limit S. pneumoniae nostril colonization, which might partly explain why children without S. pneumoniae colonization have higher levels of nasal Corynebacterium. This work narrows the gap between descriptive studies and the needed in-depth understanding of the molecular mechanisms of microbe-microbe interactions that help shape the human microbiome. It also lays the foundation for future in vivo studies to determine whether habitat modification by C. accolens could be promoted to control pathogen colonization.


Subject(s)
Antibiosis , Corynebacterium/metabolism , Fatty Acids, Nonesterified/metabolism , Nasal Cavity/microbiology , Skin/microbiology , Streptococcus pneumoniae/physiology , Triglycerides/metabolism , Anti-Bacterial Agents/pharmacology , Carrier State/microbiology , Child , Child, Preschool , Corynebacterium/chemistry , Fatty Acids, Nonesterified/pharmacology , Humans , Hydrolysis , Infant , Microbiota , Pneumococcal Infections/prevention & control , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/growth & development , Triolein/metabolism
3.
PLoS One ; 8(7): e67845, 2013.
Article in English | MEDLINE | ID: mdl-23861820

ABSTRACT

Selenium (Se) is an essential micronutrient that exerts its functions via selenoproteins. Little is known about the role of Se in inflammatory bowel disease (IBD). Epidemiological studies have inversely correlated nutritional Se status with IBD severity and colon cancer risk. Moreover, molecular studies have revealed that Se deficiency activates WNT signaling, a pathway essential to intestinal stem cell programs and pivotal to injury recovery processes in IBD that is also activated in inflammatory neoplastic transformation. In order to better understand the role of Se in epithelial injury and tumorigenesis resulting from inflammatory stimuli, we examined colonic phenotypes in Se-deficient or -sufficient mice in response to dextran sodium sulfate (DSS)-induced colitis, and azoxymethane (AOM) followed by cyclical administration of DSS, respectively. In response to DSS alone, Se-deficient mice demonstrated increased morbidity, weight loss, stool scores, and colonic injury with a concomitant increase in DNA damage and increases in inflammation-related cytokines. As there was an increase in DNA damage as well as expression of several EGF and TGF-ß pathway genes in response to inflammatory injury, we sought to determine if tumorigenesis was altered in the setting of inflammatory carcinogenesis. Se-deficient mice subjected to AOM/DSS treatment to model colitis-associated cancer (CAC) had increased tumor number, though not size, as well as increased incidence of high grade dysplasia. This increase in tumor initiation was likely due to a general increase in colonic DNA damage, as increased 8-OHdG staining was seen in Se-deficient tumors and adjacent, non-tumor mucosa. Taken together, our results indicate that Se deficiency worsens experimental colitis and promotes tumor development and progression in inflammatory carcinogenesis.


Subject(s)
Carcinogenesis/metabolism , Colitis/metabolism , Colonic Neoplasms/metabolism , Selenium/deficiency , 8-Hydroxy-2'-Deoxyguanosine , Animals , Azoxymethane , Carcinogenesis/chemically induced , Carcinogenesis/genetics , Carcinogenesis/immunology , Colitis/chemically induced , Colitis/genetics , Colitis/immunology , Colonic Neoplasms/chemically induced , Colonic Neoplasms/genetics , Colonic Neoplasms/immunology , DNA Damage , Deoxyguanosine/analogs & derivatives , Deoxyguanosine/chemistry , Dextran Sulfate , Diet , Epidermal Growth Factor/genetics , Epidermal Growth Factor/immunology , Gene Expression Regulation , Inflammation/chemically induced , Inflammation/genetics , Inflammation/immunology , Inflammation/metabolism , Mice , Mice, Inbred C57BL , Signal Transduction , Transforming Growth Factor beta/genetics , Transforming Growth Factor beta/immunology , Weight Loss
4.
Free Radic Biol Med ; 40(7): 1210-9, 2006 Apr 01.
Article in English | MEDLINE | ID: mdl-16545689

ABSTRACT

The allergic inflammation occurring in asthma is believed to be accompanied by the production of free radicals. To investigate the role of free radicals and the cells affected we turned to a murine model of allergic inflammation produced by sensitization to ovalbumin with subsequent aerosol challenge. We examined oxidant stress by measuring and localizing the sensitive and specific marker of lipid peroxidation, the F2-isoprostanes. F2-isoprostanes in whole lung increased from 0.30 +/- 0.08 ng/lung at baseline to a peak of 0.061 +/- 0.09 ng/lung on the ninth day of daily aerosol allergen challenge. Increased immunoreactivity to 15-F2t-IsoP (8-iso-PGF2alpha) or to isoketal protein adducts was found in epithelial cells 24 h after the first aerosol challenge and at 5 days in macrophages. Collagen surrounding airways and blood vessels, and airway and vascular smooth muscle, also exhibited increased immunoreactivity after ovalbumin challenge. Dietary vitamin E restriction in conjunction with allergic inflammation led to increased whole lung F2-isoprostanes while supplemental vitamin E suppressed their formation. Similar changes in immunoreactivity to F2-isoprostanes were seen. Airway responsiveness to methacholine was also increased by vitamin E depletion and decreased slightly by supplementation with the antioxidant. Our findings indicate that allergic airway inflammation in mice is associated with an increase in oxidant stress, which is most striking in airway epithelial cells and macrophages. Oxidant stress plays a role in the production of airway responsiveness.


Subject(s)
Asthma/physiopathology , F2-Isoprostanes/physiology , Oxidative Stress , Animals , Asthma/immunology , Bronchoalveolar Lavage Fluid/chemistry , Cytokines/metabolism , Disease Models, Animal , Female , Lipid Peroxidation/drug effects , Lung/immunology , Lung/physiology , Macrophages, Alveolar/chemistry , Methacholine Chloride , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Ovalbumin/immunology , Specific Pathogen-Free Organisms , Spectrometry, Mass, Electrospray Ionization , Vitamin E/administration & dosage , Vitamin E/blood , Vitamin E Deficiency/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL